CLINICAL_TRIALS
trial_result
· 2020-09-25
Clinical Trial Update: Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy [Phase 3]
Summary
Phase 3 trial update for oliceridine (TRV130) in moderate to severe acute pain after bunionectomy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Trevena Inc. | Conditions: Acute Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-09-25